Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift.

Journal: JNCI cancer spectrum
Published Date: Mar 1, 2023

Abstract

On November 30, 2022, OpenAI enabled public access to ChatGPT, a next-generation artificial intelligence with a highly sophisticated ability to write, solve coding issues, and answer questions. This communication draws attention to the prospect that ChatGPT and its successors will become important virtual assistants to patients and health-care providers. In our assessments, ranging from answering basic fact-based questions to responding to complex clinical questions, ChatGPT demonstrated a remarkable ability to formulate interpretable responses, which appeared to minimize the likelihood of alarm compared with Google's feature snippet. Arguably, the ChatGPT use case presents an urgent need for regulators and health-care professionals to be involved in developing standards for minimum quality and to raise patient awareness of current limitations of emerging artificial intelligence assistants. This commentary aims to raise awareness at the tipping point of a paradigm shift.

Authors

  • Ashley M Hopkins
    Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Jessica M Logan
    Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
  • Ganessan Kichenadasse
    College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia; Flinders Centre for Innovation in Cancer, Department of Medical Oncology, Flinders Medical Centre, Flinders University, Bedford Park, South Australia, Australia.
  • Michael J Sorich
    Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.

Keywords

External Resources

Popular Topics
Recent Journals